EUVIMEDEUVIMED entdecken
Open Access

A Target Trial Emulation to Investigate Kidney Protection from Statin Initiation in Adults with Normal Kidney Function

Franco W T Cheng iD, Ivy L Mak, Zoey C T Wong iD, Jacqueline J Wang iD, Emily T Y Tse iD, Sydney C W Tang iD, Ian C K Wong iD, Eric Y F Wan iD

Clinical Journal of the American Society of Nephrology · 2026

DOI: 10.2215/cjn.0000001107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, 2026. Verfasst von Franco W T Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Glomerular Filtration Rate, Kidney, Kidney Diseases. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Excellent Young Scientists Fund, National Natural Science Foundation of China, Excellent Young Scientists Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Statin initiation in adults with normal kidney function lowered risks of mortality and major adverse kidney events. Statins yielded modest yet clinically meaningful absolute risk reductions for mortality and GFR declines. The observed pleiotropic benefits justified using statins for simultaneous cardiovascular risk reduction and kidney protection.

Background

Evidence on the kidney-protective effects of statins in individuals with normal kidney function is mixed, with some trials suggesting benefits and others raising concerns about AKI. This study evaluates the effect of statin initiation on kidney function in adults with normal kidney function.

Methods

Sequential target trial emulation on the basis of electronic health records in the Hong Kong Hospital Authority were conducted. Patients aged 18 year or older with normal kidney function (eGFR ≥60 ml/min per 1.73 m 2 ) who met the indication for statin therapy ( i.e ., LDL-cholesterol ≥100 mg/dl without cardiovascular disease or ≥70 mg/dl with cardiovascular diseases) in Hong Kong between January 2008 and December 2017 were included. Statin initiators and noninitiators were matched using 1:1 propensity score matching. Hazard ratio (HR) and 10-year absolute risk reduction (ARR) of outcomes, including impaired kidney function (eGFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsGlomerular Filtration RateKidneyKidney DiseasesHumansMaleFemaleAgedMiddle AgedHong KongCardiovascular Diseases

Stichwörter der Autor:innen

CKDGFRcohort studiesdyslipidemiaepidemiology and outcomeskidney dysfunctionlongitudinal data analysisstatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • School of Pharmacy, The University of Auckland, Auckland, New Zealand.
  • Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Division of Nephrology, Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Aston Centre of Excellence in Pharmacotherapy Optimisation and Pharmacoepidemiology Research, Aston Pharmacy School, Aston University, Birmingham, United Kingdom.
  • School of Pharmacy, Macau University of Science and Technology, Macau Special Administrative Region, China.

ORCID-Profile: Franco W T Cheng, Zoey C T Wong, Jacqueline J Wang, Emily T Y Tse, Sydney C W Tang, Ian C K Wong, Eric Y F Wan

Förderung

  • Excellent Young Scientists Fund, National Natural Science Foundation of China
  • Excellent Young Scientists Fund
  • National Natural Science Foundation of China

Zitieren

APA

Cheng, F. W. T., Mak, I. L., Wong, Z. C. T., Wang, J. J., Tse, E. T. Y., Tang, S. C. W., Wong, I. C. K., & Wan, E. Y. F. (2026). A Target Trial Emulation to Investigate Kidney Protection from Statin Initiation in Adults with Normal Kidney Function. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001107

Vancouver

Cheng FWT, Mak IL, Wong ZCT, Wang JJ, Tse ETY, Tang SCW, et al. A Target Trial Emulation to Investigate Kidney Protection from Statin Initiation in Adults with Normal Kidney Function. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001107

BibTeX
@article{Cheng2026,
  author = {Cheng, Franco W T and Mak, Ivy L and Wong, Zoey C T and Wang, Jacqueline J and Tse, Emily T Y and Tang, Sydney C W and Wong, Ian C K and Wan, Eric Y F},
  title = {A Target Trial Emulation to Investigate Kidney Protection from Statin Initiation in Adults with Normal Kidney Function},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.2215/cjn.0000001107}
}
Kostenlos starten →